Skip to content
Screener

Pacific Biosciences of California PACB Product revenue — Total Revenue

Other product segments

Consumable revenue
$20.11M+6.2%
Instrument revenue
$12.84M-9.3%
Service and other revenue
$6.06M-9.4%

Similar metrics at other companies

PTH
PTHSNet product revenues — Total Revenue
$10.67M—
CareDx logo
CDNAProduct revenue — Total Revenue
$10.35M-4.3%
Veracyte logo
VCYTProduct revenue — Total Revenue
$3.68M+2.8%
Idexx Laboratories logo
IDXXProduct revenue — Total Revenue
$666.12M+16.2%
XPEL, Inc. logo
XPELProduct revenue — Total Revenue
$111.67M+17.8%
Illumina logo
ILMNTotal product revenue — Total Revenue
$982M+7.7%

Other financials

Income statement

See full
Revenue$39.0M-1.9%
Gross profit$12.6M-13.9%
Operating income-$44.6M+0.5%
Net income-$44.7M-6.7%
EPS (diluted)-$0.140.0%

Balance sheet

See full
Cash & equivalents$62.6M+10.5%
Total debt$61.8M+17.1%
Total equity-$33.2M-154%
Total assets$751.9M-8.9%

Cash flow

See full
Operating cash flow-$35.6M-21.1%
CapEx$1.6M+183%
Free cash flow-$37.1M-24.1%

Valuation

See full
Market cap$357.46M-5.6%
Enterprise value$356.64M-4.8%
P/S2.2×-0.2×

Profitability

See full
Gross margin36.4%+15.0pp
Operating margin-83.5%-37.4pp
Net margin-82.5%-35.5pp
FCF margin-77.5%-13.2pp

Returns & leverage

See full
Return on equity-273.6%+314pp
Debt / equity25.1×+24.5×
Current ratio4.9×-2.0×

Where this comes from

Reported directly by Pacific Biosciences of California in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Pacific Biosciences of California’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 5:30 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001299130-26-000122
(In thousands, except per share amounts)Three Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Revenue:
Product revenue$32,950$33,083$64,484$64,196
Service and other revenue6,0576,68311,70112,723
Total revenue39,00739,76676,18576,919
Cost of Revenue:
Cost of product revenue20,94420,02240,91646,355
Cost of service and other revenue5,2424,8539,4248,631
Amortization of acquired intangible assets1831833664,528

Item 1. Financial Statements (unaudited):

FAQ

What is Pacific Biosciences of California's product revenue — total revenue?
Pacific Biosciences of California (PACB) reported product revenue — total revenue of $32.95M in Q2 2026.
How has Pacific Biosciences of California's product revenue — total revenue changed year-over-year?
Pacific Biosciences of California's product revenue — total revenue decreased by 0.4% year-over-year, from $33.08M to $32.95M.
What does product revenue — total revenue mean?
This metric represents the total gross revenue generated specifically from the sale of physical products, such as sequencing instruments and consumables, within the company's genetic analysis platform. It serves as a primary indicator of market adoption and the commercial scale of the company's core hardware and reagent offerings. Tracking this figure helps investors assess the company's ability to monetize its proprietary technology and grow its installed base of sequencing systems.

Ask your AI about Pacific Biosciences of California's product revenue — total revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude